Literature DB >> 17210345

Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse.

Shih-An Liu1, Yong-Kie Wong, Jin-Ching Lin, Chiu-Kwan Poon, Kwong-Chung Tung, Wen-Chen Tsai.   

Abstract

OBJECTIVE: The aim of this study was to investigate whether the recurrence interval influenced the survival of oral cavity squamous cell carcinoma patients after relapse. STUDY DESIGN AND
SETTING: Retrospective charts were reviewed at a medical center.
METHODS: We retrospectively reviewed 1687 chart records of oral cancer patients. Statistical methods included descriptive statistics, bivariate analyses, Kaplan-Meier survival analyses, and Cox proportional hazard models for investigating the relationship between the recurrence interval and survival of oral cancer patients after relapse.
RESULTS: Local recurrence rate was 31.3 percent. Kaplan-Meier survival analyses showed the 5-year overall survival after recurrence was 31.56 percent. Cox proportional hazard model revealed that those with recurrence interval less than 18 months tended to have a higher probability of death than those with recurrence interval greater than or equal to 18 months (relative risk, 1.743; 95% confidence interval, 1.298-2.358).
CONCLUSION: The interval from initial treatment to recurrence is an independent prognostic factor for oral squamous cell carcinoma patients. Those with a shorter disease-free interval tend to have a less favorable outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17210345     DOI: 10.1016/j.otohns.2006.07.002

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  20 in total

1.  Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma.

Authors:  Fábio Roberto Pinto; Leandro Luongo de Matos; Filipe Cavalcanti Palermo; Marco Aurélio Vamondes Kulcsar; Beatriz Godói Cavalheiro; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Cláudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-27       Impact factor: 2.503

2.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

3.  Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma.

Authors:  Huan-Chun Lin; Chung-Jan Kang; Shiang-Fu Huang; Hung-Ming Wang; Chien-Yu Lin; Li-Yu Lee; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-26       Impact factor: 9.236

Review 4.  Surgical salvage of recurrent cancer of the head and neck.

Authors:  Mark Zafereo
Journal:  Curr Oncol Rep       Date:  2014-05       Impact factor: 5.075

5.  Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.

Authors:  Alexandre Caula; Marc Boukhris; Joanne Guerlain; Yungan Tao; Ingrid Breuskin; Haitham Mirghani; Stéphane Temam; Philippe Gorphe
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

6.  Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.

Authors:  M Grimm
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

7.  Relative Expression of SOX2 and OCT4 in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia.

Authors:  Narges Ghazi; Narges Aali; Vahid-Reza Shahrokhi; Farnaz Mohajertehran; Nasrollah Saghravanian
Journal:  Rep Biochem Mol Biol       Date:  2020-07

8.  Follow up after IMRT in oral cavity cancer: update.

Authors:  Gabriela Studer; Michelle Brown; Marius Bredell; Klaus W Graetz; Gerhard Huber; Claudia Linsenmeier; Yousef Najafi; Oliver Riesterer; Tamara Rordorf; Stephan Schmid; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2012-06-11       Impact factor: 3.481

9.  Cytokeratins (CK7 and CK20) Genes Expression Association with Clinicopathological Indices in Oral Squamous Cell Carcinoma and Dysplastic Oral Epithelium.

Authors:  Mehdi Shahabinejad; Reza Zare; Farnaz Mohajertehran; Atefeh Amouzad Mahdiraji
Journal:  Rep Biochem Mol Biol       Date:  2021-04

10.  Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma.

Authors:  Gerhard Frank Huber
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.